RecruitingNCT04340817
Fatty Liver Disease in Nordic Countries
Fatty Liver Disease in Nordic Countries (FLINC): a Prospective Cohort Study
Sponsor
Copenhagen University Hospital, Hvidovre
Enrollment
634 participants
Start Date
Sep 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
A prospective cohort study, which aims to systematically evaluate biomarkers and potential targets in NAFLD and NASH.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Non-alcoholic fatty liver disease and
- Healthy volunteers
Exclusion Criteria2
- Other liver diseases than non-alcoholic fatty liver disease
- Lack of informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTProteomics
Mass-spectometry proteomics
DIAGNOSTIC_TESTTranscriptomics
Next generation sequencing
GENETICGenomics
Targeted genetics
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04340817
Related Trials
Evaluating the Safety and Efficacy of Carbocisteine in the Treatment of Nonalcoholic Fatty Liver Disease Patients
NCT068633761 location
Liver Steatosis in Pediatric CD Patients
NCT062066162 locations
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
NCT058903651 location
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
NCT0722118843 locations
CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
NCT056231501 location